Estrogen signaling plays a key role in BC carcinogenesis and it is mediated by two receptors belonging to the nuclear receptor superfamily: ERα and ERβ, encoded by the ESR1 and ESR2 genes, respectively [6,7], that play opposite roles in hormone-responsive breast cancer progression. This evidence concerns the gene ESR2 and breast cancer.